NUSS JOHN (Chief Scientific Officer) sold 2.6% of their position (13.16K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $29.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/19/2024ACC: 0001415889-24-029920
Officer· Chief Scientific Officer
Since Oct 2021
-13.16K
Net shares
Net seller
$29.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
34.93K acquired · 48.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+34.93K
Price / share
—
Trade value
—
% of position
7.5%
12/17/2024
463.93K→498.86K
Common Stock
Direct
Shares
−13.16K
Price / share
$2.26
Trade value
$29.68K
% of position
2.6%
12/19/2024
498.86K→485.70K
Total
Net shares
+21.77K
Net value
-$29.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/17/2024 | M · Option Exercise | +34.93K | — | — | 7.5% | 463.93K | 498.86K |
| Common Stock Direct | 12/19/2024 | S · Sale | −13.16K | $2.26 | $29.68K | 2.6% | 498.86K | 485.70K |
| Total | +21.77K | -$29.68K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
34.93K shares
Shares
−34.93K
Strike price
Held after
34.93K
Exercisable
—
12/17/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock34.93K shares | 12/17/2024 | M · Option Exercise | −34.93K | — | 34.93K |